Associations of 25-Hydroxyvitamin D2and D3with Cardiovascular Risk Factors in Childhood: Cross-Sectional Findings from the Avon Longitudinal Study of Parents and Children
Open Access
- 1 May 2012
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (5) , 1563-1571
Abstract
Context: Studies in adults have reported associations of low circulating total 25-hydroxyvitamin D with increased cardiovascular disease and risk factors. Evidence of associations in children, however, is limited, and it is unknown whether associations with risk factors differ for each 25-hydroxyvitamin D analog [25-hydroxyvitamin D2 (25[OH]D2) and 25-hydroxyvitamin D2 (25[OH]D3)]. Objective: The objective of the study was to compare associations of 25(OH)D2 and 25(OH)D3 with cardiovascular risk factors in children. Design/Setting: The design of the study was a cross-sectional study of 4274 children (mean age 9.9 yr) from the Avon Longitudinal Study of Parents and Children. Main Outcomes: The main outcomes included blood pressure, lipids [triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDL-C)], apolipoproteins (Apo-A1 and Apo-B), adiponectin, leptin, C-reactive protein, and IL-6. Results: In confounder-adjusted models, 25(OH)D2 was inversely associated with Apo-A1 (change per doubling of exposure: −0.74mg/dl; 95% confidence interval −0.14, −0.04) and triglycerides (relative percentage change per doubling of exposure: −1.64%; −3.27, 0.01) and positively associated with C-reactive protein (8.42%; 3.40, 13.58) and IL-6 (5.75%; 1.83, 9.25). 25(OH)D3 was positively associated with HDL-C (0.04 mmol/liter; 0.02, 0.06), Apo-A1 (1.96 mg/dl; 0.65, 3.24), and adiponectin (0.47 μg/ml; 0.15, 0.79). There was statistical evidence that associations of 25(OH)D2 and 25(OH)D3 with HDL-C, Apo-A1, and IL-6 differed from each other (all P values for differences ≤0.02). Conclusions: Higher circulating 25(OH)D3 was associated with cardioprotective levels of HDL-C, Apo-A1, and adiponectin in children. Associations of 25(OH)D2 with cardiovascular risk factors were in mixed directions. It is necessary to see whether these associations are replicated in large prospective studies.Keywords
This publication has 42 references indexed in Scilit:
- Long-term Variation in Serum 25-Hydroxyvitamin D Concentration among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialCancer Epidemiology, Biomarkers & Prevention, 2010
- Hypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?The Journal of Clinical Endocrinology & Metabolism, 2010
- Relationships between 25-Hydroxyvitamin D Levels and Plasma Glucose and Lipid Levels in Pediatric OutpatientsThe Journal of Pediatrics, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Vitamin D Status and the Risk of Cardiovascular Disease DeathAmerican Journal of Epidemiology, 2009
- Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent PopulationPediatrics, 2009
- Vitamin D Deficiency and Risk for Cardiovascular DiseaseThe American Journal of the Medical Sciences, 2009
- Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the CommunityCirculation, 2009
- Phosphate Levels and Cardiovascular Disease in the General PopulationClinical Journal of the American Society of Nephrology, 2009
- Comparing Methods for Accounting for Seasonal Variability in a Biomarker When Only a Single Sample Is Available: Insights From Simulations Based on Serum 25-Hydroxyvitamin DAmerican Journal of Epidemiology, 2009